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Abstract: Bullous dermolysis of the newborn (BDN) is a subtype of
dystrophic epidermolysis bullosa caused by mutations in type VII
collagen resulting in disorganized anchoring fibrils and sublamina densa
blister formation. Disease activity is usually confined to the first year of
life, with restoration of physiologic type VII collagen localization. We
report four new cases of BDN and review the utility of immunofluores-
cence mapping in establishing the diagnosis.
Bullous dermolysis of the newborn (BDN), for-
merly known as transient bullous dermolysis of
the newborn, is a subtype of autosomal dominant
or recessive dystrophic epidermolysis bullosa (EB)
characterized by mechanical fragility of the skin and
blister formation primarily conﬁned to infancy (1).
Histologically a subepidermal blister forms below the
lamina densa, and electron microscopy demonstrates
disruption of anchoring ﬁbrils and the presence of
electron-dense stellate or rod-like bodies within
dilated rough endoplasmic reticulum of basal kerat-
inocytes (2). Independently, intracytoplasmic accu-
mulation of type VII collagen in basal keratinocytes
was detected in patients with clinical features consis-
tent with BDN (3). This aberrant accumulation was
self-limited, with type VII collagen localization
reverting to linear distribution along the dermoepi-
dermal junction (DEJ) with improvement in disease
activity (4). The precise mechanisms of this reversal
have not been elucidated. Several molecular defects in
BDN were reported involving COL7A1 mutations
that probably result in abnormal intracytoplasmic
processing, delayed transport, and intraepidermal
accumulation of type VII collagen (5–8).
Because of the self-limiting and usually benign
clinical course of BDN, as well as characteristic
ﬁndings of granular intraepidermal type VII collagen
staining on immunoﬂuorescence (IF) studies, it is
important to distinguish this form of dystrophic EB.
IF mapping using speciﬁc monoclonal antibodies is
currently recommended as the primary diagnostic
evaluation for patients with suspected inherited EB
(1). Here we report four cases of BDN, two of which
occurred in siblings, and highlight the importance of
clinical follow-up and immunologic studies in estab-
lishing the diagnosis.
METHODS
Immunoﬂuorescence mapping (Beutner Laboratories,
Buﬀalo, NY) was performed using antibodies against
type VII collagen (LH 7:2) (3), type IV collagen,
Address correspondence to Tor Shwayder, M.D., Department
of Dermatology, Henry Ford Hospital, 3031 W Grand Blvd., Suite
800, Detroit, MI 48202, or e-mail: TShwayd1@hfhs.org.
DOI: 10.1111/pde.12230
736 © 2013 Wiley Periodicals, Inc.
CASE REPORTS
Pediatric Dermatology Vol. 30 No. 6 736–740, 2013
keratin 14, laminin 332, α6 integrin, β4 integrin, type
XVII collagen, and plectin.
CASE REPORTS
Patient 1
A 2,500-g Caucasian boy was born at 36 and 3/
7 weeks gestation via vaginal delivery. Pregnancy was
complicated by maternal hypertension. At birth,
desquamation of the right foot was noted and he
subsequently developed blisters and erosions in the
areas of friction. There was no family history of
blistering diseases. Physical examination revealed
bullae, vesicles, and erosions involving the right lower
extremity, the right periauricular area, and portions of
the scalp, thumb, and midback (Fig. 1A, B). Both
parents were interviewed and the skin of their upper
extremities, head, and neck was examined. We found
no evidence of blistering disease in their history or
current physical examination. Punch biopsies of intact
blisters on the left knee were performed and submitted
for hematoxylin and eosin (H&E) staining and IF.
H&E staining showed a paucicellular subepidermal
vesicle, with periodic acid-Schiﬀ–positive basement
membrane in the ﬂoor of the vesicle, most consistent
with EB of the junctional type. IF showed localization
of laminin and type IV collagen along the intact DEJ.
Type IV collagen was expressed solely in the roof of
the central subepidermal microvesicle, consistent with
sublamina densa split and dystrophic EB. Type VII
collagen was detected in the roof but not the ﬂoor of
the microvesicle, with prominent focal granular
deposits of collagen VII in the cytoplasm of epidermal
cells and interrupted staining along the DEJ
(Fig. 2A), compared with linear staining in a healthy
skin control (Fig. 2D). The presence of type VII
collagen excluded severe generalized recessive dystro-
phic EB, previously known as Hallopeau–Siemens.
Type XVII collagen and α6 and β4 integrins were
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Figure 1. Appearance of the skin lesions. Patient 1: (A) large bulla on the right foot and (B) vesicle on the right thumb at
3 days of age. (C) Patient 2: erosion involving the dorsum of the left foot with the loss of the great toenail at 5 days of age.
(D) Patient 2: tongue erosion at 16 days of age. Patient 3: (E) milia and hyper- and hypopigmented patches on the left ankle
at the site of a previous lesion and (F) an erythematous patch with milia on the left hand at 5 weeks of age.
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present in the roof of the microvesicle and basement
membrane zone of the intact epidermis.
At the 16-week follow-up he had developed tongue
and right heel erosions after trauma. At the 7-month
visit, no new blisters were reported or identiﬁed on
examination. There were hyperpigmented macules
and milia in the areas of previous erosions and
scarring loss of the right great toenail. At the 2-year
follow-up he remained blister free. Based on clinical
resolution of blistering and IF ﬁndings of prominent
intraepidermal type VII collagen granules, he was
diagnosed with BDN. Genetic testing was oﬀered to
the patient and his parents, but they declined because
of the prohibitive cost.
Patient 2
A full-term 3,500-g Caucasian boy was born via
spontaneous vaginal delivery. The pregnancy and
delivery were uncomplicated. He was the younger
brother of patient 1. He presented at birth with
desquamation of the left foot. On skin examination at
5 days of age he had erosions involving the extremities
(with the loss of the left great toenail) and tongue
(Fig. 1C, D). Punch biopsy of the ﬂaccid blister on the
posterior left calf was performed and submitted for IF
only. Laminin and type IV collagen were normally
expressed along the intact DEJ. Type IV collagen was
expressed exclusively in the roof of the cleft, consistent
with a sublamina densa split and dystrophic EB.
Staining for type VII collagen revealed weak, focal
positive staining at the roof of the cleft and absent
staining at the ﬂoor of the cleft (Fig. 2B). One or two
foci of granular type VII collagen were noted in the
epidermis (Fig. 2B), although they were much less
prominent than in patient 1. Staining for ﬁbrin was
positive (data not shown), probably indicating that
the biopsied lesion was older and had some reparative
changes. The remainder of the tested antigens were
present in the roof of the cleft, although overall IF
staining of this biopsy specimen was less intense,
probably because of the age of the lesion or a staining
artifact.
At 7 weeks he had a new erosion secondary to
trauma. The last erosion occurred at 4 months of age,
and he had no new blisters at the 6-month follow-up.
Based on clinical course, family history, and IF
ﬁndings, he was diagnosed with BDN.
Patient 3
A full-term 3,400-g Filipino boy was born via spon-
taneous vaginal delivery. The pregnancy and delivery
were uncomplicated. At 1 day of age he developed
multiple blisters on the abdomen, dorsal hands, and
feet. There was no family history of bullous diseases.
On examination at 5 weeks of age he had hyper- and
hypopigmented macules on the left ankle at the
previous erosion site and milia were present on the
bilateral hands and left foot (Fig. 1E). He also had
several erythematous macules and patches on the
dorsum of both hands (Fig. 1F), both ankles, and
abdomen. An intact vesicle was biopsied and sent for
IF. Review of an H&E-stained pathology slide of a
blister sent at birth demonstrated a cell-poor subepi-
dermal blister, consistent with EB. On IF, laminin and
type IV collagen were normally expressed along the
intact DEJ. Type IV collagen was expressed exclu-
sively in the roof of several subepidermal micro-
vesicles, consistent with a sublamina densa split and
dystrophic EB. Type VII collagen was uniformly
present at the DEJ, and granular intraepidermal
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Figure 2. Immunofluorescence mapping using anti-type VII collagen antibody. (A) Patient 1: left knee skin biopsy. (B)
Patient 2: left calf skin biopsy. (C) Patient 3: right medial foot skin biopsy. (D) Normal human skin, used as a positive control.
Arrows indicate the location of intraepidermal granules.
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staining was not observed in any of the examined
sections (Fig. 2C). Type XVII collagen and α6 and β4
integrins were present in the roof of microvesicles and
the basement membrane zone of the intact epidermis.
Clinically the blistering resolved spontaneously by
3 months of age, and he remained blister free at
5 months of age. Although type VII collagen staining
did not demonstrate a granular pattern, his clinical
course was most consistent with BDN.
Patient 4
A full-term 3,600-g Caucasian boy was born via
caesarean section for arrest of labor. The pregnancy
was complicated by pruritic urticarial papules and
plaques of pregnancy starting in the second trimester.
Within hours after birth he developed blisters and
erosions on the scalp, lip, inside the mouth, in the
axilla, and on the lower extremities. He has a distant
paternal relative who was diagnosed with EB,
unknown type, and died at 3 months of age in 1978.
On initial examination he had multiple superﬁcial
erosions involving the face, hands, arms, feet, and
legs. A punch biopsy specimen of a blister on day 2 of
life was submitted for H&E and IF. H&E demon-
strated subepidermal cleft-like separation at the DEJ
consistent with EB. IF demonstrated a separated
epidermis with focally attached dermis fragments with
a scant amount of intact DEJ, suggesting that the
punch specimen came apart during transport, making
interpretation of the IF results diﬃcult. Type IV
collagen staining was strongly positive in the roof of
the microvesicles, with weak focal positive staining in
the ﬂoor of the microvesicles. Linear localization of
laminin along the DEJ was observed, as well as in the
roof, but not the ﬂoor, of the microvesicles. Type VII
collagen was detected along the intact DEJ and in the
roof but not the ﬂoor of the microvesicles, with
prominent focal granular deposits of collagen VII in
the cytoplasm of epidermal cells (data not shown).
Type XVII collagen and α6 and β4 integrins were
present in the roof of the microvesicles and basement
membrane zone of the intact epidermis. Although
collagen IV staining was atypical, antigen localization
was indicative of a sublamina densa split and dystro-
phic EB. The presence of prominent type VII collagen
granules was consistent with BDN.
His last blister was at 5 months of age. He had
delayed tooth appearance and brown discoloration
despite appropriate dental hygiene, with bottom teeth
appearing at 11 months and top teeth at 15 months.
His big toenails are dystrophic. At the 17-month
follow-up he remained blister-free.
DISCUSSION
The most recent classiﬁcation scheme (1) of inherited
EB speciﬁes the following clinical features of BDN:
autosomal dominant or recessive pattern of inheri-
tance; onset of blisters at birth or infancy; generalized
skin distribution of blisters; variable presence of milia,
atrophic scarring, and dystrophic or absent nails; and
absence of extracutaneous involvement and skin
cancer predisposition, although the most important
characteristic of BDN is arguably its limited duration.
In the majority of published cases with BDN diagno-
sis, blisters resolved by 1 to 7 months of age (2–18).
Current classiﬁcation does not indicate the duration
of blistering as a diagnostic criterion and eliminated
the term “transient” because rare patients exhibited
blister formation, albeit diminished, beyond 12
months (4,10). In our patients, the blistering disap-
peared by 3 to 7 months of age, similar to most
reported cases of BDN. Although BDN has an overall
benign and limited course, certain functional compli-
cations such as pseudosyndactyly (7) or aesthetic
complications such as nail dystrophy and residual
scarring may be of concern to individual patients.
Electron microscopy was used initially to charac-
terize a structural defect in BDN, but is impractical
for widespread clinical use (1). With the development
of speciﬁc antibodies, the presence of intracytoplas-
mic type VII collagen granules within keratinocytes
emerged as an important ﬁnding in patients with
BDN and was reported in all 17 proband patients in
whom IF was performed, but intraepidermal collagen
VII staining is not speciﬁc to BDN and has been noted
at various intensities and frequencies in other dystro-
phic EB phenotypes (14,19,20). It is more likely that
the relative abundance of intraepidermal staining is
associated with BDN (14). Loss of intraepidermal
staining and localization of type VII collagen to the
DEJ appears to coincide with the resolution of
blistering. Granular intraepidermal staining has been
reported in family members many years after blister-
ing stopped (6). Therefore infants presenting with a
blistering disorder and intraepidermal type VII colla-
gen granules on IF may have BDN, but their parents
should be counseled that clinical follow-up is essential
in establishing the diagnosis.
Conversely, the absence of intraepidermal type VII
collagen granules does not exclude BDN because they
may be rare in a given biopsy, the biopsy may have
been performed after distribution of type VII collagen
to the DEJ, or IF staining may be suboptimal because
of the quality of the specimen. In patient 2, the blister
was probably more than 24 hours old, as evidenced by
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positive ﬁbrin staining, and this may have accounted
for the poor collagen VII granular staining and
overall poor specimen quality. In patient 3, intraepi-
dermal granules were not detected, but his blistering
had already diminished by the time the biopsy
specimen was obtained, and his clinical course
otherwise fulﬁlled BDN criteria. Thus prominent
intraepidermal type VII collagen staining is highly
suggestive of BDN but is not essential for a clinical
BDN diagnosis.
Several diﬀerent mutations in type VII collagen
have been identiﬁed in BDN (5–8), however, the
speciﬁc eﬀects of these mutations on type VII collagen
protein structure and function have not been deter-
mined. In addition, the cost of individual gene
sequencing is prohibitive. Once techniques to trans-
late gene sequences into protein structures and func-
tions become widely available, individual sequencing
will play an important role in establishing the diag-
nosis and identifying pathogenic mutations.
In summary, we present four cases seen in our
practice that met the diagnostic criteria for BDN. We
found that three of four met IF mapping criteria for
this condition. The clinical course is the critical
diagnostic criterion, with IF as a secondary aid. In
our cases, blistering ceased between 3 and 7 months of
age. Intraepidermal granular deposits of type VII
collagen are helpful but are not required for the
diagnosis.
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